ATA199387A - Verfahren zur herstellung eines oralen therapeutischen systems fuer carbamazepin - Google Patents

Verfahren zur herstellung eines oralen therapeutischen systems fuer carbamazepin

Info

Publication number
ATA199387A
ATA199387A AT871993A AT199387A ATA199387A AT A199387 A ATA199387 A AT A199387A AT 871993 A AT871993 A AT 871993A AT 199387 A AT199387 A AT 199387A AT A199387 A ATA199387 A AT A199387A
Authority
AT
Austria
Prior art keywords
carbamazepine
producing
therapeutic system
oral therapeutic
oral
Prior art date
Application number
AT871993A
Other languages
English (en)
Other versions
AT397344B (de
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ATA199387A publication Critical patent/ATA199387A/de
Application granted granted Critical
Publication of AT397344B publication Critical patent/AT397344B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT0199387A 1986-08-07 1987-08-06 Verfahren zur herstellung eines oralen therapeutischen systems für carbamazepin AT397344B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3172/86A CH668187A5 (de) 1986-08-07 1986-08-07 Therapeutisches system mit systemischer wirkung.

Publications (2)

Publication Number Publication Date
ATA199387A true ATA199387A (de) 1993-08-15
AT397344B AT397344B (de) 1994-03-25

Family

ID=4250176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0199387A AT397344B (de) 1986-08-07 1987-08-06 Verfahren zur herstellung eines oralen therapeutischen systems für carbamazepin

Country Status (30)

Country Link
US (1) US4857336A (de)
JP (1) JP2592460B2 (de)
KR (1) KR950006219B1 (de)
AT (1) AT397344B (de)
AU (1) AU597403B2 (de)
BE (1) BE1000235A3 (de)
CA (1) CA1302267C (de)
CH (1) CH668187A5 (de)
DD (1) DD285718A5 (de)
DE (1) DE3725824C2 (de)
DK (1) DK175497B1 (de)
ES (1) ES2007100A6 (de)
FI (1) FI86143C (de)
FR (1) FR2602425B1 (de)
GB (1) GB2193632B (de)
GR (1) GR871234B (de)
HK (1) HK33793A (de)
HU (1) HU206978B (de)
IE (1) IE59718B1 (de)
IL (1) IL83386A (de)
IT (1) IT1215618B (de)
LU (1) LU86966A1 (de)
MY (1) MY100767A (de)
NL (1) NL194780C (de)
NO (1) NO173726C (de)
NZ (1) NZ221347A (de)
PH (1) PH25090A (de)
PT (1) PT85489B (de)
SE (1) SE502590C2 (de)
ZA (1) ZA875804B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3868077D1 (de) * 1987-01-14 1992-03-12 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
DE69227240T2 (de) * 1991-01-16 1999-04-08 Fmc Corp., Philadelphia, Pa. Träger für wirkstoffe und damit hergestellte feste darreichungsformen
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US6296873B1 (en) 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
BR9812553B1 (pt) 1997-09-25 2010-06-01 formulação medicamentosa em pélete de difusão controlada e em um sistema matriz.
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
EP1079813B1 (de) * 1998-04-29 2005-02-09 Virotex Corporation Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US7964216B2 (en) * 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
IN190699B (de) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
US20040156900A1 (en) * 2001-04-10 2004-08-12 Shanghvi Dilip Shantilal Time pulsed release composition
RU2189225C1 (ru) * 2001-09-14 2002-09-20 Нестерук Владимир Викторович Лекарственное средство на основе карбамазепина
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
TW200302748A (en) * 2002-02-01 2003-08-16 Pfizer Prod Inc Osmotic delivery system
US6572889B1 (en) 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
WO2003075830A2 (en) * 2002-03-14 2003-09-18 Sun Pharmaceutical Industries Limited Oral controlled drug delivery system containing carbamazepine
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
RU2240798C1 (ru) * 2003-06-25 2004-11-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая противосудорожным и психотропным действием, и способ ее получения
EP1690540A1 (de) * 2005-02-15 2006-08-16 Neuro3D Zusammensetzung enthaltend Ocaperidon
WO2006116247A1 (en) * 2005-04-25 2006-11-02 Teva Pharmaceuticals Usa, Inc. Extended release formulations
US20070071819A1 (en) * 2005-05-30 2007-03-29 Kesarwani Amit K Multiple unit modified release compositions of carbamazepine and process for their preparation
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
US20090143362A1 (en) * 2007-12-04 2009-06-04 Barabde Umesh Vinayakrao Carbamazepine formulations
EP2240162A4 (de) 2007-12-06 2013-10-09 Bend Res Inc Nanoteilchen mit einem nicht-ionisierbaren polymer und einem amin-funktionalisierten methacrylat-copolymer
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
MX352959B (es) 2011-08-18 2017-12-15 Biodelivery Sciences Int Inc Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina.
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) * 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump

Also Published As

Publication number Publication date
NL8701857A (nl) 1988-03-01
FI873409A7 (fi) 1988-02-08
FI86143C (fi) 1992-07-27
AU7661787A (en) 1988-02-11
HUT44930A (en) 1988-05-30
ZA875804B (en) 1988-02-08
CA1302267C (en) 1992-06-02
JPS6344525A (ja) 1988-02-25
IL83386A0 (en) 1987-12-31
SE8703034D0 (sv) 1987-08-03
DD285718A5 (de) 1991-01-03
PH25090A (en) 1991-02-19
DE3725824C2 (de) 1998-12-17
NO173726C (no) 1994-01-26
GB2193632A (en) 1988-02-17
KR950006219B1 (ko) 1995-06-12
NO173726B (no) 1993-10-18
ES2007100A6 (es) 1989-06-01
JP2592460B2 (ja) 1997-03-19
DE3725824A1 (de) 1988-02-11
PT85489A (en) 1987-09-01
IT8748270A0 (it) 1987-08-05
GR871234B (en) 1987-12-08
FR2602425A1 (fr) 1988-02-12
PT85489B (pt) 1990-06-29
FR2602425B1 (fr) 1990-09-14
NZ221347A (en) 1989-12-21
NL194780C (nl) 2003-03-04
IL83386A (en) 1992-01-15
NO873298L (no) 1988-02-08
KR880002511A (ko) 1988-05-09
AU597403B2 (en) 1990-05-31
FI873409A0 (fi) 1987-08-05
CH668187A5 (de) 1988-12-15
HU206978B (en) 1993-03-01
DK175497B1 (da) 2004-11-15
GB2193632B (en) 1990-04-25
MY100767A (en) 1991-02-14
SE502590C2 (sv) 1995-11-20
DK410787A (da) 1988-02-08
SE8703034L (sv) 1988-02-08
FI86143B (fi) 1992-04-15
GB8717643D0 (en) 1987-09-03
DK410787D0 (da) 1987-08-06
HK33793A (en) 1993-04-16
IE872110L (en) 1988-02-07
BE1000235A3 (fr) 1988-09-20
LU86966A1 (fr) 1989-03-08
IE59718B1 (en) 1994-03-23
NO873298D0 (no) 1987-08-06
AT397344B (de) 1994-03-25
NL194780B (nl) 2002-11-01
US4857336A (en) 1989-08-15
IT1215618B (it) 1990-02-22

Similar Documents

Publication Publication Date Title
DE3679361D1 (de) Verfahren zur herstellung endossaler implantate.
DE3682846D1 (de) Verfahren zur herstellung endossaler implantate.
ATA112385A (de) Verfahren zur herstellung wenigstens zweilagiger gegenstände
DE3676741D1 (de) Verfahren zur herstellung endossaler implantate.
DE3787394D1 (de) Verfahren zur Herstellung positiver Abbildungen.
ATA117386A (de) Stehtank und verfahren zur herstellung desselben
DE3876869D1 (de) Photodetektor fuer ultraviolett und verfahren zur herstellung.
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
DE69016884D1 (de) Verfahren zur Herstellung von tertiären Alkoholen.
DE3686444D1 (de) N-fluorpyridiniumsalz und verfahren zur herstellung.
DE3877558D1 (de) Verfahren zur herstellung polybromierter hoeherer alkylbenzole.
DE3773356D1 (de) Polyvinylalkoholfaser und verfahren zur herstellung derselben.
ATA903983A (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
DE59004909D1 (de) Verfahren zur herstellung symmetrischer difettsäurediamide.
DE3684430D1 (de) Verfahren zur herstellung eines bildes.
DE3781767D1 (de) Verfahren zur herstellung einer extra-oralen zahnrestauration.
DE3880640D1 (de) Verfahren zur herstellung aliphatischer o-arylurethane.
DE3650051D1 (de) Verfahren zur Herstellung einer Roentgenlinse.
DE59205061D1 (de) Verfahren zur Herstellung keilförmiger Strukturen
DE3851218D1 (de) Verfahren zur herstellung optisch aktiver verbindungen.
DE3668634D1 (de) Verfahren zur herstellung phosphorhaltiger polyarylenaether.
DE3870775D1 (de) Verfahren zur herstellung von kieselsaeuregelteilchen.
DE3669511D1 (de) Verfahren zur herstellung von halogenierten trialkylphosphatestern.
DE3762619D1 (de) Verfahren zur herstellung monomerer alpha-cyanacrylate.
DE3761767D1 (de) Verfahren zur herstellung optisch aktiver 2-hydroxyethyl-azol- derivate.

Legal Events

Date Code Title Description
ELA Expired due to lapse of time